# EDGAR Filing Document

**Accession Number:** 0001965903
**File Stem:** 0001773751-25-000253
**Filing Date:** 2025-8
**Character Count:** 8135
**Document Hash:** a83b9b919dd8f97ffcd43968ab50a93d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001773751-25-000253.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0001773751-25-000253

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250804

**DATE AS OF CHANGE**: 20250804

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Chi Michael
- **CENTRAL INDEX KEY:** 0001965903

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38986
- **FILM NUMBER:** 251180567

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST., #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hims & Hers Health, Inc.
- **CENTRAL INDEX KEY:** 0001773751
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
- **BUSINESS PHONE:** 415-851-0195

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oaktree Acquisition Corp.
- **DATE OF NAME CHANGE:** 20190412

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Chi Michael<br><sub>(Last) (First) (Middle)</sub><br>2269 CHESTNUT STREET, #523<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94123<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-31 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Commercial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hims & Hers Health, Inc. [ HIMS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2025-07-31 |  | M<sup>(1)</sup> |  | 3600 | A | $13.90 | 282254 | D |  |
| Class A Common Stock | 2025-07-31 |  | M<sup>(1)</sup> |  | 14700 | A | $5.01 | 296954 | D |  |
| Class A Common Stock | 2025-07-31 |  | M<sup>(1)</sup> |  | 6300 | A | $6.82 | 303254 | D |  |
| Class A Common Stock | 2025-07-31 |  | M<sup>(1)</sup> |  | 1750 | A | $11.53 | 305004 | D |  |
| Class A Common Stock | 2025-07-31 |  | S<sup>(1)</sup> |  | 26350 | D | $67 | 278654 | D |  |
| Class A Common Stock | 2025-08-01 |  | M<sup>(1)</sup> |  | 250 | A | $11.53 | 278904 | D |  |
| Class A Common Stock | 2025-08-01 |  | S<sup>(1)</sup> |  | 250 | D | $64.44 | 278654 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | $13.90 | 2025-07-31 |  | M<sup>(1)</sup> |  |  | 3600 | <sup>(2)</sup> | 2031-05-27 | Class A Common Stock | 3600 | $0 | 7800 | D |  |
| Stock Option (right to buy) | $5.01 | 2025-07-31 |  | M<sup>(1)</sup> |  |  | 14700 | <sup>(3)</sup> | 2032-02-24 | Class A Common Stock | 14700 | $0 | 178242 | D |  |
| Stock Option (right to buy) | $6.82 | 2025-07-31 |  | M<sup>(1)</sup> |  |  | 6300 | <sup>(4)</sup> | 2032-08-10 | Class A Common Stock | 6300 | $0 | 118062 | D |  |
| Stock Option (right to buy) | $11.53 | 2025-07-31 |  | M<sup>(1)</sup> |  |  | 1750 | <sup>(5)</sup> | 2033-03-01 | Class A Common Stock | 1750 | $0 | 47856 | D |  |
| Stock Option (right to buy) | $11.53 | 2025-08-01 |  | M<sup>(1)</sup> |  |  | 250 | <sup>(5)</sup> | 2033-03-01 | Class A Common Stock | 250 | $0 | 47606 | D |  |

---

### Footnotes:

(1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

(2) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.

(3) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

(4) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

(5) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

**Signature:** /s/ Alexandra Cotter Wilkins, Attorney-in-Fact  
**Date:** 2025-08-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**